Proxy advisory firms support merger of Invitrogen, Applied Biosystems

By Lisa Kerner

Charlotte, N.C., Oct. 6 - RiskMetrics Group/ISS; Glass, Lewis & Co. and Proxy Governance, Inc. all recommended that Invitrogen Corp. shareholders and Applied Biosystems Inc. shareholders vote to approve the companies' merger.

Both companies will hold special meetings on Oct. 16, an Invitrogen news release said.

In June, Invitrogen agreed to acquire Applera Corp.'s Applied Biosystems for $38 per share in a cash and stock transaction valued at $6.7 billion.

Invitrogen is a Carlsbad, Calif.-based provider of life science technologies for disease research, drug discovery and commercial bioproduction.

Applied Biosystems is a developer and marketer of instrument-based systems, consumables, software and services. The company is located in Norwalk, Conn.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.